C07D 263/20
Attached in position 2
Official title: attached in position 2
C07D263/20 (Attached in position 2) appears on 818 US grants and 662 published applications in this corpus.
Search patents in C07D- Granted patents
- 818
- Published applications
- 662
- Assignees
- 422
- Inventors
- 2,528
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 10 | 0 |
| 1978 | 5 | 0 |
| 1979 | 5 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 6 | 0 |
| 1984 | 16 | 0 |
| 1985 | 11 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 9 | 0 |
| 1989 | 14 | 0 |
| 1990 | 14 | 0 |
| 1991 | 20 | 0 |
| 1992 | 23 | 0 |
| 1993 | 22 | 0 |
| 1994 | 8 | 0 |
| 1995 | 20 | 0 |
| 1996 | 21 | 0 |
| 1997 | 25 | 0 |
| 1998 | 24 | 0 |
| 1999 | 16 | 0 |
| 2000 | 19 | 0 |
| 2001 | 31 | 5 |
| 2002 | 27 | 35 |
| 2003 | 34 | 41 |
| 2004 | 25 | 43 |
| 2005 | 20 | 37 |
| 2006 | 24 | 37 |
| 2007 | 25 | 35 |
| 2008 | 26 | 28 |
| 2009 | 9 | 36 |
| 2010 | 23 | 31 |
| 2011 | 13 | 22 |
| 2012 | 14 | 18 |
| 2013 | 11 | 23 |
| 2014 | 23 | 26 |
| 2015 | 17 | 27 |
| 2016 | 28 | 34 |
| 2017 | 30 | 23 |
| 2018 | 18 | 25 |
| 2019 | 17 | 22 |
| 2020 | 18 | 26 |
| 2021 | 12 | 14 |
| 2022 | 12 | 14 |
| 2023 | 11 | 18 |
| 2024 | 10 | 20 |
| 2025 | 15 | 15 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Industrial synthesis of serinol6 Oct 2026US 12,753,146 B2Bracco Imaging S.P.A.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors6 Jan 2026US 12,516,046 B2Merck Sharp & Dohme Corp.
- Hepatitis B antiviral agents16 Dec 2025US 12,496,282 B2Enanta Pharmaceuticals, Inc.
- Substituted oxazolidinones and imidazolinones as herbicides24 Sep 2026US 2026/0285850 A1FMC Corporation
- Method for producing o-substituted serine derivative27 Aug 2026US 2026/0250241 A1Chugai Seiyaku Kabushiki Kaisha
- Process for preparing an n-substituted-2-oxazolidinone23 Jul 2026US 2026/0209192 A1Huntsman Petrochemical Corporation
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
Most cited
By later US patents
- Fluorochemical oxazolidinones161US 5,025,052 AMinnesota Mining and Manufacturing Company · 1991
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Substituted oxazine and thiazine oxazolidinone antimicrobials113US 5,688,792 APharmacia & Upjohn Company · 1997
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001